Catechins and the treatment of breast cancer: Possible utility and mechanistic targets

IDrugs

Volumn 6, Issue 11, 2003, Pages 1073-1078

  Rosengren, Rhonda J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Breast cancer; Epicatechin gallate; Epigallocatechin; Epigallocatechin gallate; Estrogen metabolism

Indexed keywords

2 HYDROXYESTRADIOL; 2 METHOXYESTRADIOL; 4 HYDROXYESTRADIOL; 4 METHOXYESTRADIOL; 4' O METHYL EPIGALLOCATECHIN GALLATE; ANTINEOPLASTIC AGENT; CATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; METHYL EPIGALLOCATECHIN GALLATE; PHYTOESTROGEN; PROBENECID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; UNCLASSIFIED DRUG; ZIDOVUDINE;

ADD ON THERAPY; ALLERGIC REACTION; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DOSE RESPONSE; DRUG COST; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; ENZYME ACTIVITY; HORMONE METABOLISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; NONHUMAN; REVIEW; SIDE EFFECT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CATECHIN; FEMALE; HUMANS; TAMOXIFEN; TEA;

EID: 0345392682     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Brinton LA, Devasa SS: Etiology and pathogenesis of breast cancer: Epidemiologic factors. In: Diseases of the Breast. Harris JR, Lippman ME, Morrow M, Hellman S (Eds), Lippincott-Raven, Philadelphia, PA, USA (1996):159-168.
2. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA (1996) 93(12):5925-5930.
3. Butler WM, Cunningham JE, Reynolds JA, Sweatman CA: Ethnic differences in estrogen receptor negativity, tumor stage, grade and histology in a retrospective breast cancer review. Breast Cancer Res Treat (2000) 64:Abs 221.
4. Kumar V, Green S, Stack G, Berry M, Jin J-R, Chambon P: Functional domains of the human estrogen receptor. Cell (1987) 51(6):941-951.
5. Tsai MJ, O'Malley BW: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem (1994) 63:451-486.
6. Jordan VC, Schafer JM, Levenson AS, Liu H, Pease KM, Simons LA, Zapf JW: Molecular classification of estrogens. Cancer Res (2001) 61(18):6619-6623.
7. American Cancer Society: Cancer facts and figures 2003. American Cancer Society, Atlanta, GA. USA (2003). http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf
8. Bianco AR, De Placido S, Perrone F, Carlomagno C, De Laurentiis M, Del Mastro L, Lauria R, Marinelli A, Gallo C: Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer. Ann NY Acad Sci (1993) 698:330-338.
9. Arts ICW, Van De Putte B, Hollman PCH: Catechin contents of foods commonly consumed in the Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J Agric Food Chem (2000) 48(5):1746-1751.
10. Graham NH: Green tea composition, consumption, and polyphenol chemistry. Prev Med (1992) 21:334-350.
11. Kuroda Y, Hara Y: Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res (1999) 436(1):69-97.
12. Imai K, Suga K, Nakachi K: Cancer-preventive effects of drinking gree tea among a Japanese population. Prev Med (1997) 26(6):769-775.
13. Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y: Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res (1998) 89(3):254-261.
14. Morre DJ, Bridge A, Wu LY, Morre DM: Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture. Biochem Pharmacol (2000) 60(7):937-946.
15. Kavanagh KT, Hafer LJ, Kim DW, Mann KK, Sherr DH, Rogers AE, Sonenshein GE: Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem (2001) 82(3):387-398.
16. Valcic S, Timmermann BN, Aberts DS, Wachter GA, Krutzsch M, Wymer J, Guillen JM: Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs (1996) 7(4):461-468. EGCG is the most potent of the catechins at inhibiting the proliferation of MCF-7 cells as compared to EGC and ECG.
17. Bray BJ: Role of Glucuronidation in the Regulation of Drug Effects. University of Otago, Dunedin, New Zealand (2003). The efficacy of the catechins was inversely correlated to the rate of glucuronidation of the cell line.
18. Liao S, Umekita Y, Guo J, Kokontis JM, Hiipakka RA: Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett (1995) 96(2):239-243. Reports the tumor inhibitory effect of EGCG in both prostate and breast tumors.
19. Hirose M, Hoshiya T, Akagi K, Futakuchi M, Ito N: Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[a]anthracene. Cancer Lett (1994) 83(1-2):149-156.
20. Tanaka H, Hirose M, Kawabe M, Sano M, Takesada Y, Hagiwara A, Shirai T: Post-initiation inhibitory effects of green tea catechins on 7,12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis in female Sprague-Dawley rats. Cancer Lett (1997) 116(1):47-52.
21. Komori A, Yatsunami J, Okabe S, Abe S, Hara K, Suganuma M, Kim SJ, Fujiki H: Anticarcinogenesis activity of green tea polyphenols. Jpn J Clin Oncol (1993) 23(3):186-190.
22. Goodin MG, Fertuck KC, Zacharewski TR, Rosengren RJ: Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro. Toxicol Sci (2002) 69(2):354-361. Catechins do not antagonize estrogen receptor-mediated responses in vivo or in vitro.
23. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, Van Der Saag PT, Van Der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology (1998) 139(10):4252-4263.
24. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD, Mendelson CR et al.: Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev (1994) 15(3):342-355.
25. Lee AJ, Kosh JW, Conney AH, Zhu BT: Characterization of the NADPH-dependent metabolism of 17β-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5. J Pharmacol Exp Ther (2001) 298(2):420-432.
26. Strott CA: Steroid sulfotransferases. Endocr Rev (1996) 17(6):670-697.
27. Turgeon D, Carrier J-S, Levesque E, Hum DW, Belanger A: Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology (2001) 142(2):778-787.
28. Raftogianis R, Creveling CR, Weinshilboum R, Weisz J: Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr (2000) (27):113-124.
29. Kao Y-H, Hiipakka RA, Liao S: Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology (2000) 141(3):980-987. EGCG reduced circulating estradiol levels.
30. Goodin MG, Rosengren RJ: Epigallocatechin gallate modulates CYP450 isoforms in the female Swiss Webster mouse. Toxicol Sci (2003): manuscript submitted. EGCG inhibited ovarian CYP19 (aromatase) and induced hepatic CYP3A.
31. Weisz J, Bui QD, Roy D, Liehr JG: Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: A potential pathway of metabolic activation of estrogens. Endocrinology (1992) 131(2):655-661.
32. Zhu BT, Conney AH: Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammery carcinogenesis? Cancer Res (1998) 58(11):2269-2277.
33. Lakhani NJ, Sarkar MA, Venitz J, Figg WD: 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy (2003) 23(2):165-172. A comprehensive review on the properties and mechanisms of 2-methoxy-estradiol and its potential as a novel cancer chemotherapy.
34. LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS: 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors α and β. Cancer Res (2002) 62(13):3691-3697.
35. Chisholm K, Rosengren RJ: Synergistic effects of catechins and tamoxifen. NZ Med J (2002) 115(1162):1-2. In vitro data demonstrating a synergistic effect between EGCG and tamoxifen in ERα breast cancer cells.
36. Nishiyama T, Ogura K, Nakano H, Ohnuma T, Kaku T, Hiratsuka A, Muro K, Watabe T: Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases. Biochem Pharmacol (2002) 63(10):1817-1830.
37. Piskula MK, Terao J: Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J Nutr (1998) 128(7):1172-1178.
38. Grancharov K, Naydenova Z, Lozeva S, Golovinsky E: Natural and synthetic inhibitors of UDP-glucuronosyltransferase. Pharmacol Ther (2001) 89(2):171-186.
39. Kuhnle G, Spencer JP, Schroeter H, Shenoy B, Debnam ES, Srai SK, Rice-Evans C, Hahn U: Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochem Biophys Res Commun (2000) 277(2):507-512.
40. Sano M, Suzuki M, Miyase T, Yoshino K, Maeda-Yamamoto M: Novel antiallergic catechin derivatives isolated from oolong tea. J Agric Food Chem (1999) 47(5):1906-1910.
41. Suzuki M, Yoshino K, Maeda-Yamamoto M, Miyase T, Sano M: Inhibitory effects of tea catechins and O-methylated derivatives of (-)-epigallocatechin-3-O-gallate on mouse type IV allergy. J Agric Food Chem (2000) 48(11):5649-5653.
42. Tachibana T, Sunada Y, Miyase T, Sano M, Maeda-Yamamoto M, Yamada K: Identification of a methylated tea catechin as an inhibitor of degranulation in human basophilic KU812 cells. Biosci Biotechnol Biochem (2000) 64(2):452-454.
43. Xie T, Ho S-L, Ramsden D: Characterization and implications of estrogenic down-regulation of human catechol O-methyltransferase gene transcription. Mol Pharmacol (1999) 56(1):31-38.
44. Cohn CK, Axelrod J: The effect of estradiol on catechol O-methyltransferase activity in rat liver. Life Sci (1971) 10(23)1351-1354. Estradiol is established to downregulate COMT by an ER-mediated mechanism.
45. Parvez S, Parves SH, Youdin MB: Variation in activity of monoamine metabolizing enzymes in rat liver during pregnancy. Br J Pharmacol (1975) 53(2):241-246.